Monitoring minimal residual disease in AML

Cytotherapy. 1999;1(4):341. doi: 10.1080/0032472031000141273.
No abstract available

MeSH terms

  • Antigens / biosynthesis
  • Cell Separation / methods*
  • Flow Cytometry / methods*
  • Humans
  • Immunophenotyping / methods*
  • Leukemia, Myeloid, Acute / blood*
  • Leukemia, Myeloid, Acute / diagnosis*
  • Medical Oncology / methods
  • Neoplasm, Residual / blood*
  • Neoplasm, Residual / diagnosis*
  • Phenotype
  • Recurrence

Substances

  • Antigens